Histological regression in primary cutaneous melanoma occurs in 10–35% of cases.
Although a large body of literature exists to suggest that histological regression serves very …

Purpose To update the American Society of Clinical Oncology (ASCO)-Society of Surgical
Oncology (SSO) guideline for sentinel lymph node (SLN) biopsy in melanoma. Methods An …

Importance The prognostic significance of regression in primary melanoma has been
debated for many years. There is no consensus regarding the need for sentinel lymph node …

Thick cutaneous melanomas (Breslow depth> 4 mm) are locally advanced tumors, generally
associated with poor prognosis. Nevertheless, these tumors sometimes display …

Sentinel node biopsy (SNB) has been at the forefront of the surgical staging of melanoma
patients for the past 15 years. The high accuracy of this prognostic staging procedure is now …

Sentinel node biopsy (SNB) is the most accurate staging tool for melanoma patients. The
procedure is indicated especially for intermediate thickness melanoma (pT2/3). SNB can be …

The prognostic significance of histological regression in primary melanoma has been
debated for many years. We aim to review the evidence to see how histological regression …

The field of melanoma genetics is moving at great pace with new platforms to investigate
single nucleotide polymorphism, genome sequencing, gene expression, and methylation …

Opinion statement The vast majority of patients newly diagnosed with melanoma present
with clinically localized disease, and sentinel lymph node biopsy (SLNB) is a standard of …

The growing repertoire of approved immune-checkpoint inhibitors and targeted therapy has
revolutionized the adjuvant treatment of melanoma. While the treatment of primary …